These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4620100)

  • 1. [Case of hypofibrinogenemia with disorders of fibrin polymerization during hepatic cirrhosis].
    Gouault-Heilmann M; Chardon E; Yvart J; Sultan C; Cattan D
    Pathol Biol (Paris); 1974 Nov; 22 suppl():80-5. PubMed ID: 4620100
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer.
    Pengo V; Levi Minzi S; Dal Bo Zanon R; Cappellato G; Farinati F; Girolami A
    J Med; 1984; 15(2):149-60. PubMed ID: 6096471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibrinogen and fibrin degradation products (FDP) in hepatic cirrhosis].
    Buraschi J; Sack ES
    Sangre (Barc); 1972; 17(1):35-42. PubMed ID: 5016795
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acanthocytosis of red blood cells. A case during hepatic cirrhosis with hemolysis and defibrination].
    Gorin NC; Gouault M; Rochan H; Dreyfus B
    Nouv Presse Med; 1975 Jan; 04(2):101-4. PubMed ID: 1138219
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypofibrinogenemia in the course of cirrhoses. A biologic study].
    Hollard D; Kolodié L
    Nouv Rev Fr Hematol; 1968; 8(1):131-5. PubMed ID: 4232757
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: A new type of congenital dysfibrinogenemia (fibrinogen Tokyo) with defective stabilization of fibrin polymers.
    Samori T; Yatabe M; Ukita M; Fujimaki M; Fukutake K
    Thromb Diath Haemorrh; 1975 Sep; 34(1):329. PubMed ID: 1188745
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinogen gamma375 arg-->trp mutation (fibrinogen aguadilla) causes hereditary hypofibrinogenemia, hepatic endoplasmic reticulum storage disease and cirrhosis.
    Rubbia-Brandt L; Neerman-Arbez M; Rougemont AL; Malé PJ; Spahr L
    Am J Surg Pathol; 2006 Jul; 30(7):906-11. PubMed ID: 16819336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Decomposition products of fibrin(ogen) and collateral circulation in liver cirrhosis].
    Bungert HJ; Leonhardt H
    Z Gastroenterol; 1973 Apr; 11(3):187-94. PubMed ID: 4803419
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombin clotting time and fibrin polymerization in liver cirrhosis.
    Szczepański M; Habior A; Szczepanik A; Soszka A; Grel K
    Mater Med Pol; 1994; 26(3):87-90. PubMed ID: 7603083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypodysfibrinogenemia: fibrinogen giessen II (author's transl)].
    Krause WH; Huth K; Heene DL; Lasch HG
    Klin Wochenschr; 1975 Aug; 53(16):781-2. PubMed ID: 1165625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in fibrin formation in liver cirrhosis].
    Fernández J; Narvaiza MJ; Cuesta B; Páramo JA; López Fernández A; Febres R; Rocha E
    Sangre (Barc); 1982; 27(4-B):705-26. PubMed ID: 7157141
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylactic administration of fibrinogen concentrate in a pregnant woman with congenital hypofibrinogenemia and a positive obstetric history of severe bleeding in previous cesarean section.
    Kaparou M; Danilatou V; Lydaki E; Stathoudakis G; Bolonaki I; Nikoloudi I; Foundouli K
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):566-8. PubMed ID: 22874742
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinogen Marseille. A new case of congenital dysfibrinogenaemia.
    Soria J; Soria C; Juhan I; Perrimond H; Haverkate F; Orsini A
    Haemostasis; 1980; 9(4):214-25. PubMed ID: 7399353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical aspects and clinical course of a case of congenital hypofibrinogenemia].
    Kruse H; Schulz K; Blau HJ
    Kinderarztl Prax; 1969 Aug; 37(8):361-72. PubMed ID: 5355994
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrin-fibrinogen degradation products in hepatic cirrhosis.
    Bulajić M; Kovacević N; Lalić M; Rolović Z
    Acta Med Iugosl; 1977; 31(4):333-8. PubMed ID: 596236
    [No Abstract]   [Full Text] [Related]  

  • 17. Congenital abnormalities of fibrinogen.
    Beck EA
    Clin Haematol; 1979 Feb; 8(1):169-81. PubMed ID: 367661
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinogen-bound sialic acid levels in the dysfibrinogenaemia of liver disease.
    Francis JL; Armstrong DJ
    Haemostasis; 1982; 11(4):215-22. PubMed ID: 6290353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum FDP in patients with congenital dysfibrinogenemia].
    Kobayashi H; Sakaguchi Y; Matsuo T
    Rinsho Byori; 1986 Aug; 34(8):973-6. PubMed ID: 3784037
    [No Abstract]   [Full Text] [Related]  

  • 20. The dysfibrinogenaemias.
    Roberts HR; Stinchcombe TE; Gabriel DA
    Br J Haematol; 2001 Aug; 114(2):249-57. PubMed ID: 11529842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.